GBA1 and Parkinson disease: Recently, it has been suggested that the effects of GBA mutations on CSF α-synuclein profiles and phenotypical characteristics seem dependent on GBA mutation severity, since PD patients carrying severe GBA mutations showed more pronounced cognitive decline and reduced CSF levels of total α-synuclein in the CSF [109].